Low dose recombinant FSH treatment may reduce multiple gestations caused by controlled ovarian hyperstimulation and intrauterine insemination

被引:18
|
作者
Papageorgiou, TC
Guibert, J
Savale, M
Goffinet, F
Fournier, C
Merlet, F
Janssens, Y
Zorn, JR
机构
[1] Hop Cochin, Clin Univ Baudelocque, Serv Gynecol Obstet 3, F-75674 Paris, France
[2] Ctr Oscar Lambret, Unite Biostat, F-59020 Lille, France
关键词
D O I
10.1111/j.1471-0528.2004.00439.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To evaluate the rate of multiple pregnancies in intrauterine insemination cycles stimulated with a minimal dose of recombinant follicle stimulating hormone (rec-FSH). Design Retrospective study. Setting University Medical Center. Population A total of 1256 patients underwent 3219 consequent intrauterine insemination cycles with minimal ovarian stimulation. Methods Patients received 50 or 75 IU of rec-FSH from day four to day seven. The dose was adjusted according to oestradiol (E-2) levels in order to achieve a maximum of two follicles on the day of hCG administration. Main outcome measures Peak E-2 levels, the number of follicles >15 mm and pregnancy rates were calculated. The predictive value of E-2 levels for multiple gestations was also estimated. Results Of 3219 cycles, 334 resulted in pregnancies (10%). Of these, 238 (91%) were singletons, 28 (8%) twins and 1 (0.3%) was a triplet. The cumulative overall pregnancy rate was 43%. Patients over 40 years old had a significantly lower pregnancy rate per cycle and overall live birth rate (P < 0.05). Most pregnancies (83%) occurred during the first three cycles. Pregnancy rates per cycle varied from 8% for tubal factor to 14% for anovulation infertility. Conclusions Minimal FSH stimulation in intrauterine insemination cycles may reduce the rates of twins and high order multiple pregnancies without affecting overall pregnancy rates.
引用
收藏
页码:1277 / 1282
页数:6
相关论文
共 43 条
  • [21] Controlled ovarian Hyperstimulation (COH) and intrauterine insemination (IUI) vs. In Vitro Fertilisation (IVF) for the first line treatment of unexplained subfertility - a randomised controlled trial
    Nandi, A.
    Gudi, A.
    Shah, A.
    Hooper, R.
    Khan, K.
    Homburg, R.
    HUMAN REPRODUCTION, 2016, 31 : 70 - 71
  • [22] Can dopamine agonist at a low dose reduce ovarian hyperstimulation syndrome in women at risk undergoing ICSI treatment cycles? A randomized controlled study
    Shaltout, Amany
    Shohyab, Amal
    Youssef, Mohamed A. F. M.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2024, 299 : 302 - 302
  • [23] Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation in IVF or ICSI treatment: a meta-analysis and critical evaluation of the evidence
    Harb, H.
    Gallos, I
    Sharif, W.
    van Wely, M.
    Coomarasamy, A.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2013, 120 : 193 - 193
  • [24] Intrauterine insemination with controlled ovarian stimulation for treatment of infertility: An audit of a new IUI programme in a low resource setting
    Ikechebelu, J. I.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2007, 27 (01) : 61 - 64
  • [25] High order multiple pregnancy resulting from controlled ovarian hyperstimulation and intrauterine insemination can be predicted by the number of preovulatory follicles, estradiol levels, and age.
    Dickey, RP
    Taylor, SN
    Lu, PY
    Sartor, BM
    Rye, PH
    Pyrzak, R
    FERTILITY AND STERILITY, 2003, 80 : S217 - S217
  • [26] Are we choosing the correct FSH starting dose during controlled ovarian stimulation for intrauterine insemination cycles? Potential application of a nomogram based on woman’s age and markers of ovarian reserve
    Rossana Di Paola
    Simone Garzon
    Sara Giuliani
    Antonio Simone Laganà
    Marco Noventa
    Francesca Parissone
    Carlotta Zorzi
    Ricciarda Raffaelli
    Fabio Ghezzi
    Massimo Franchi
    Stefano Zaffagnini
    Archives of Gynecology and Obstetrics, 2018, 298 : 1029 - 1035
  • [27] Are we choosing the correct FSH starting dose during controlled ovarian stimulation for intrauterine insemination cycles? Potential application of a nomogram based on woman's age and markers of ovarian reserve
    Di Paola, Rossana
    Garzon, Simone
    Giuliani, Sara
    Lagana, Antonio Simone
    Noventa, Marco
    Parissone, Francesca
    Zorzi, Carlotta
    Raffaelli, Ricciarda
    Ghezzi, Fabio
    Franchi, Massimo
    Zaffagnini, Stefano
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2018, 298 (05) : 1029 - 1035
  • [28] The elimination of estradiol (E2) monitoring during controlled ovarian hyperstimulation (COH) with intrauterine insemination (IUI) will lead to acceptable pregnancy rates without an increase in high order multiple gestation or ovarian hyperstimulation syndrome (OHSS).
    Rodriguez, C
    Strawn, EY
    Karcaaltincabal, D
    Reinke, M
    Lehman, P
    Eastwood, D
    FERTILITY AND STERILITY, 2003, 80 : S184 - S184
  • [29] A prospective, randomized controlled trial comparing highly purified hMG with recombinat FSH plus recombinant LH in women undergoing intrauterine insemination: Ovarian response and clinical outcomes.
    Labarta, E.
    Bosch, E.
    Simon, C.
    Remohi, J.
    Pellicer, A.
    FERTILITY AND STERILITY, 2007, 88 : S295 - S296
  • [30] A PROSPECTIVE RANDOMIZED STUDY COMPARING CLOMIPHENE CITRATE SUPPLEMENTED WITH RECOMBINANT FSH OR LOW-DOSE HCG IN OVARIAN STIMULATION FOR INTRU-TERINE INSEMINATION.
    Kabouk, G. B.
    Donadio, N. F.
    Dzik, A.
    Freitas, G. C.
    Justen, R.
    Cavagna, M.
    FERTILITY AND STERILITY, 2010, 94 (04) : S160 - S160